This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.
This book brings together a collection of innovative papers on strategies for analyzing the spatial and economic impacts of disasters. Natural and human-induced disasters pose several challenges for conventional modeling. For example, disasters entail complex linkages between the natural, built, and socio-economic environments. They often create chaos and economic disequilibrium, and can also cause unexpected long-term, structural changes. Dynamic interactions among agents and behavioral adjustments in a disaster become complicated. The papers in this volume make notable progress in tackling these challenges through refinements of conventional methods, as well as new modeling frameworks and multidisciplinary, integrative strategies. The papers also provide case study applications that afford new insights on disaster processes and loss reduction strategies.
Iva Ikuku Toguri (1916-2006) was an American citizen, born on the 4th of July. Her parents, first-generation Japanese Americans, embraced their new nation and raised Iva to think, talk, and act like a patriotic American. But, despite her allegiance to the United States, she was forced to spend most of her adult life denying that she was a traitor or that she was World War II's infamous Tokyo Rose. When the Japanese attacked Pearl Harbor, Iva was nursing an ailing aunt in Japan. Prevented from returning to home, she was viewed with suspicion by the Japanese authorities. They hounded her to renounce her American citizenship, which she adamantly refused to do. Pressured to find employment, she joined Radio Tokyo. Known as Orphan Ann, she did nothing more than emcee brief music segments on "The Zero Hour" during the war's last two years. She was never called "Tokyo Rose" by anyone and was but one of only a dozen or so English-speaking females heard on Japanese airwaves. In need of money to return home after the war, she made the mistake of allowing herself to be interviewed by two ambitious journalists who were certain that she was the Tokyo Rose, even though she denied it. The published story brought Iva to the attention of American authorities who tried and convicted Iva for treason, despite the lack of evidence and a reluctant jury. She was then stripped of her citizenship and sent to prison. Yasuhide Kawashima's account of Toguri's trials are deeply rooted in Japanese language sources, American legal archives, and the cultures of both nations. He identifies heroes and villains in both the United States and Japan and also highlights broader concerns: the internment of thousands of loyal Japanese Americans, the meaning of citizenship, the nation's commitment to the idea of fair trial, the impact of tabloid journalism, and the very concept of treason. Iva was eventually pardoned in 1977 by President Gerald Ford—she was the first person in U.S. history to be pardoned for treason—and had her citizenship restored. Yet when she died in 2006, obituaries continued to identify her as Tokyo Rose. Kafkaesque in its telling, Kawashima's tale provides a harsh reminder that the law does not always render justice.
Electromagneto-Mechanics of Material Systems and Structures Electromagneto-Mechanics of Material Systems and Structures Written by a leading expert, this book is a comprehensive introduction to the fundamentals and the state of the art in the electromagneto-mechanics of adaptive materials. Its varied topic range includes an overview on how electric, magnetic, and deformation fields interact with each other in the presence of advanced materials systems, such as electric conductors, dielectrics, ferromagnets, among others. Within this context, the author considers for each material system specific phenomena like vibrations, wave propagation, fracture, and fatigue. Readers will also gain a thorough understanding of applications in the electronics and nuclear energy industries, as well as in smart materials and MEMS. Covers a wide and varied range of subject areas, spanning theoretical, experimental, computational studies as well as industrial applications Features extensive applications in the electronics, nuclear engineering, smart materials and MEMS industries Takes the reader from fundamental concepts, applied research, applications through to emerging technologies Electromagneto-Mechanics of Material Systems and Structures is an all-in-one reference for advanced/graduate students in mechanical and electrical engineering, as well as materials science. It also serves as a handy refresher guide for engineers in related areas such as aeronautical and civil engineering.
This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.